Omda (OMDA) Stock Overview
Provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 5/6 |
| Past Performance | 3/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
OMDA Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Omda AS Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NOK 40.00 |
| 52 Week High | NOK 57.40 |
| 52 Week Low | NOK 33.10 |
| Beta | 0.42 |
| 1 Month Change | 2.56% |
| 3 Month Change | -16.49% |
| 1 Year Change | 9.59% |
| 3 Year Change | 0% |
| 5 Year Change | -58.33% |
| Change since IPO | -51.81% |
Recent News & Updates
Recent updates
Returns On Capital Are Showing Encouraging Signs At Omda (OB:OMDA)
Oct 10
Omda AS (OB:OMDA) Stock Rockets 32% As Investors Are Less Pessimistic Than Expected
May 23These 4 Measures Indicate That Omda (OB:OMDA) Is Using Debt Extensively
May 16
Restructuring, Acquisitions And AI Integration Will Secure Operational Efficiency
Restructuring completion and an enhanced acquisition strategy are expected to boost operational efficiency, revenue growth, and earnings.Little Excitement Around Omda AS' (OB:OMDA) Revenues
Apr 08Omda (OB:OMDA) Has A Somewhat Strained Balance Sheet
Jan 26The Market Doesn't Like What It Sees From Omda AS' (OB:OMDA) Revenues Yet
Dec 21Returns On Capital Are Showing Encouraging Signs At Omda (OB:OMDA)
Nov 13Returns At Omda (OB:OMDA) Are On The Way Up
Jul 24Omda's (OB:OMDA) Earnings Are Weaker Than They Seem
May 22Improved Revenues Required Before Omda AS (OB:OMDA) Stock's 28% Jump Looks Justified
Mar 24Fewer Investors Than Expected Jumping On Omda AS (OB:OMDA)
Jan 24Omda's (OB:OMDA) Earnings May Just Be The Starting Point
Nov 18Are Investors Undervaluing CSAM Health Group AS (OB:CSAM) By 44%?
Jun 17Shareholder Returns
| OMDA | NO Healthcare Services | NO Market | |
|---|---|---|---|
| 7D | 0% | 0.9% | -0.9% |
| 1Y | 9.6% | 1.8% | 37.6% |
Return vs Industry: OMDA exceeded the Norwegian Healthcare Services industry which returned 2.6% over the past year.
Return vs Market: OMDA underperformed the Norwegian Market which returned 39.5% over the past year.
Price Volatility
| OMDA volatility | |
|---|---|
| OMDA Average Weekly Movement | 6.5% |
| Healthcare Services Industry Average Movement | 6.6% |
| Market Average Movement | 5.1% |
| 10% most volatile stocks in NO Market | 10.8% |
| 10% least volatile stocks in NO Market | 3.1% |
Stable Share Price: OMDA has not had significant price volatility in the past 3 months compared to the Norwegian market.
Volatility Over Time: OMDA's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 255 | Sverre Flatby | omda.com |
Omda AS provides software solutions for the healthcare and emergency response sector in Norway, Sweden, Denmark, Finland, and internationally. The company offers laboratory information management systems consisting of Omda ProSang, a blood, cell, and tissue management system; and medical medication solution comprising Omda Cytodose, an oncology medication management solution. It also provides connected healthcare solutions, including Omda Cardio, an ECG and diagnostic storage tool; Omda CIMA, a clinical imaging mobile application; Omda Media, a web-based medical imaging solution; Omda Medimaker, an image management and workflow solution; Omda Picsara, an image management solution; Omda Arcidis, an integrated teleradiology system; Omda Helsemail, an patient data transfer tool; Omda Plutus, an audit and workflow monitoring platform; Omda S7, a secure e-care communications platform; and Omda XDS, a patient data storage and management solution.
Omda AS Fundamentals Summary
| OMDA fundamental statistics | |
|---|---|
| Market cap | NOK 820.31m |
| Earnings (TTM) | NOK 6.61m |
| Revenue (TTM) | NOK 495.69m |
Is OMDA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OMDA income statement (TTM) | |
|---|---|
| Revenue | NOK 495.69m |
| Cost of Revenue | NOK 314.30m |
| Gross Profit | NOK 181.39m |
| Other Expenses | NOK 174.79m |
| Earnings | NOK 6.61m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
May 21, 2026
| Earnings per share (EPS) | 0.32 |
| Gross Margin | 36.59% |
| Net Profit Margin | 1.33% |
| Debt/Equity Ratio | 1,833.4% |
How did OMDA perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/04/10 06:35 |
| End of Day Share Price | 2026/04/10 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Omda AS is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kristian Støle | Carnegie Investment Bank AB |
| Emilie Engen | DNB Carnegie |
| Eirik Rafdal | DNB Carnegie |